It can mediate the activation of the G2/M cell cycle checkpoint, inhibit the phosphorylation of cyclin-dependent kinase 1 (Cyclin-dependent kinase 1, CDK1), and block the progression of the tumor cell cycle. The gene discussed is CDK1; the disease is neoplasm.